Quidel Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $17.0M | 583 | 77.0% |
| Consulting Fee | $3.1M | 262 | 14.2% |
| Current or prospective ownership or investment interest | $751,300 | 10 | 3.4% |
| Royalty or License | $588,376 | 37 | 2.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $254,943 | 33 | 1.2% |
| Food and Beverage | $136,191 | 3,386 | 0.6% |
| Honoraria | $123,944 | 54 | 0.6% |
| Travel and Lodging | $75,930 | 79 | 0.3% |
| Education | $4,100 | 3 | 0.0% |
| Debt forgiveness | $675.67 | 7 | 0.0% |
| Gift | $84.44 | 4 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| SARS | $5.2M | 0 | 82 |
| Sofia 2 RVP4 | $1.3M | 0 | 17 |
| CS-0605-03: Savanna RVP4 Validation Study | $1.3M | 0 | 31 |
| Strep 98 | $959,320 | 1 | 67 |
| CS-0103-04: QuickVue Flu and QuickVue RSV Field Study | $905,055 | 0 | 21 |
| CS-0908-01:High Sensitivity Near Patient Cardiac Troponin (High Note) - Triage | $846,341 | 0 | 35 |
| CS-0172-01: QuickVue ABC Validation Study | $665,177 | 0 | 4 |
| CS-274-07: Sofia RVP4 Validation Study with New Cassette Format | $632,832 | 0 | 11 |
| QuickVue at Home | $549,939 | 0 | 19 |
| Sofia2 Lyme Disease | $431,867 | 0 | 24 |
| RVP4 | $407,965 | 1 | 13 |
| QuickVue Influenza A+B | $397,008 | 0 | 20 |
| CS-0393-03: Lyra Direct SARS-CoV-2 and Lyra SARS-CoV-2 Validation Study | $369,327 | 0 | 10 |
| Feasibility Testing on Self-Collected Samples with Nexus Labs | $340,545 | 0 | 15 |
| CS-0290-01: Sofia SARS+ Validation Study | $306,487 | 0 | 12 |
| Rapid Influenza Nasal Home Collection Kit | $296,039 | 0 | 8 |
| CS-0908-01-High Note | $253,724 | 6 | 70 |
| CS-0393-01: Lyra Direct SARS CoV-2 Specimen Procurement | $222,250 | 0 | 21 |
| Sofia Lyme Disease | $207,483 | 0 | 22 |
| CS-0164-07: QuickVue At-Home COVID-19 Validation | $121,600 | 0 | 2 |
| Sofia 2 Flu + SARS | $112,593 | 0 | 4 |
| CS-289-02: Sofia Flu and Flu + SARS Comparison Study | $94,993 | 0 | 2 |
| Covid-19 Sophia | $84,566 | 0 | 2 |
| Triage Tox Ds X | $79,020 | 0 | 1 |
| Savanna RVP4/11 Validation Study CS-0605-02 | $78,468 | 0 | 3 |
| CS-0605-04 :Savanna RVP4+ Reproducibility Study | $64,000 | 0 | 2 |
| Sofia2 Strep A | $59,250 | 0 | 7 |
| QuickVue At-Home COVID-19 Reproducibility Study | $57,000 | 0 | 1 |
| CS-0921-01:Sample Collection for the Alignment of Triage BNP on the Quidel Triage MeterPro and the Beckman Coulter Immunoassay System (LEGEND-2) | $53,405 | 0 | 7 |
| Flu+SARS Validation Study | $46,910 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Unknown Provider | — | — | $2,800 | $0 |
| Michelle Owens, Md, MD | Obstetrics & Gynecology | Indianapolis, IN | $2,733 | $0 |
| Michael Cymbor, Od, OD | Optometrist | State College, PA | $2,725 | $0 |
| Dr. John Sheppard, M.d, M.D | Ophthalmology | Norfolk, VA | $2,613 | $0 |
| Dr. Alan Kabat, O.d, O.D | Optometrist | Philadelphia, PA | $2,584 | $0 |
| Dr. Thomas Kislan, O.d, O.D | Optometrist | Stroudsburg, PA | $2,575 | $0 |
| Dr. Martin Grajower, Md, MD | Endocrinology, Diabetes & Metabolism | Bronx, NY | $2,500 | $0 |
| Dr. Laura Periman, Md, MD | Cornea and External Diseases Specialist | Seattle, WA | $2,443 | $0 |
| Nicole Hubbard, Md, MD | Clinical Pathology | Toledo, OH | $2,271 | $0 |
| Dr. John Williams, Md, MD | Anesthesiology | Pittsburgh, PA | $2,000 | $0 |
| Justin Schweitzer, O.d, O.D | Optometrist | Sioux Falls, SD | $1,971 | $0 |
| Alice Epitropoulos, M.d, M.D | Ophthalmology | Columbus, OH | $1,720 | $0 |
| Douglas Devries, O.d, O.D | Optometrist | Sparks, NV | $1,630 | $0 |
| Unknown Provider | — | — | $1,600 | $0 |
| Dr. Ashley Brissette, Md, MD | Ophthalmology | New York, NY | $1,579 | $0 |
| Gregory Caldwell, O.d, O.D | Optometrist | Duncansville, PA | $1,531 | $0 |
| Scott Prysi, M.d, M.D | General Practice | Monterey, CA | $1,500 | $0 |
| Dr. Bincy Abraham, Md, MD | Gastroenterology | Houston, TX | $1,500 | $0 |
| Sean Mccloy, Do, DO | Emergency Medicine | Appleton, WI | $1,500 | $0 |
| Patricia Ferrieri, Md, MD | Pediatric Infectious Diseases | Minneapolis, MN | $1,497 | $0 |
| Scott Hauswirth, Od, OD | Corneal and Contact Management | Bloomington, MN | $1,487 | $0 |
| Maria Lizette Harris, D.o, D.O | Pediatrics | Dallas, TX | $1,456 | $0 |
| Dr. Marcial Oquendo Rincon, M.d, M.D | General Practice | Dallas, TX | $1,456 | $0 |
| Carmen Pagan, M.d, M.D | Pediatrics | Palm Bay, FL | $1,456 | $0 |
| Dr. Alan Wu, D.c, D.C | Chiropractor | San Francisco, CA | $1,445 | $0 |
Top Products
- Sofia2 $7.1M
- QuickVue $2.8M
Associated Products (19)
- Sofia2 $7.1M
- QuickVue $3.4M
- Triage $2.7M
- Sofia 2 $982,290
- QuickVue At-Home $619,924
- Eye Health $426,338
- R-Mix $380,546
- Savanna $173,377
- Quickvue At-Home $150,107
- QuickVue Professional Use $106,000
- FGF-23 $78,802
- TBI $56,664
- InflammaDry $52,594
- Sofa 2 $46,569
- Super E-Mix $40,919
- MicroVue Bone $31,977
- Solana $27,320
- TriageTrue $13,725
- MicroVue $12,388
Payment Categories
- Food & Beverage $136,191
- Consulting $3.1M
- Travel & Lodging $75,930
- Research $17.0M
- Royalties $588,376
About Quidel Corporation
Quidel Corporation has made $22.1M in payments to 2,500 healthcare providers, recorded across 4,458 transactions in the CMS Open Payments database. In 2023, the company paid $6.7M. The top product by payment volume is Sofia2 ($7.1M).
Payments were distributed across 100 medical specialties. The top specialty by payment amount is Obstetrics & Gynecology ($2.3M to 29 doctors).
Payment categories include: Food & Beverage ($136,191), Consulting ($3.1M), Research ($17.0M), Travel & Lodging ($75,930), Royalties ($588,376).
Quidel Corporation is associated with 19 products in the CMS Open Payments database, including Sofia2, QuickVue, and Triage.